Duchenne's Muscular Dystrophy (DMD) Terminated Phase 2 / 3 Trials for Ataluren (DB05016)

Also known as: Duchenne's Muscular Dystrophy / Duchenne Muscular Dystrophy (DMD) / Duchenne Muscular Dystrophy / Muscular Dystrophy, Duchenne / Muscular dystrophy

IndicationStatusPhase
DBCOND0066749 (Duchenne's Muscular Dystrophy (DMD))Terminated2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00847379Phase 2b Extension Study of Ataluren (PTC124) in Duchenne/Becker Muscular Dystrophy (DMD/BMD)Treatment